RHEIA Trial: Transcatheter vs surgical aortic valve replacement in women with severe aortic stenosis

by michaelg September 1, 2024

Video by PCR via YouTube
Go to Source

Chiara De Biase interviews Helene Eltchaninoff about the results of the RHEIA trial she presented at the ESC Congress 2024 in London.

RHEIA showed that TAVI was superior to surgery in women with severe aortic stenosis, reducing death, stroke, and rehospitalization. #TAVI also offered a shorter hospital stay, suggesting it could be the preferred treatment for these patients.

More news about the #ESCcongress 2024 on PCRonline: https://www.pcronline.com/News/Whats-new-on-PCRonline/2024/ESC/PCRonline-ESC-Congress-2024

Go to Source

A patient with severe aortic stenosis - Webinar On… by Michaelg
Contemporary surgical & transcatheter treatment… by Michaelg
Timing of intervention in patients with severe… by Michaelg
Timing of intervention in patients with severe… by Michaelg
How do I ensure long valve durability for my TAVI… by Michaelg
EARTH-STEMI: Complete revascularisation benefits in… by Michaelg

# education # innovation # innovative

RHEIA Trial: Transcatheter vs surgical aortic valve replacement in women with severe aortic stenosis

Related Posts: